NCT00361036View on ClinicalTrials.gov

Comparison Study in the Treatment of Uterine Fibroids Uterine Fibroid Embolization Using BeadBlock™ Embolic Agent

PHASE1CompletedINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

August 31, 2006

Primary Completion Date

March 31, 2010

Study Completion Date

March 31, 2010

Conditions

LeiomyomaLeiomyomatosisUterine Neoplasms

Interventions

DEVICE

Uterine fibroid embolization BeadBlock™

Intervention with BeadBlock Microspehere

DEVICE

Uterine fibroid embolization Embosphere®

Embosphere - control arm

Trial Locations (2)

12208

Albany Medical Center, Albany

19464

Image Guided Surgery Associates, Pottstown

All Listed Sponsors

collaborator

Terumo Medical Corporation

INDUSTRY

collaborator

Biocompatibles UK Ltd

INDUSTRY

lead

Worthington-Kirsch, Robert L., M.D.

INDIV

NCT00361036 - Comparison Study in the Treatment of Uterine Fibroids Uterine Fibroid Embolization Using BeadBlock™ Embolic Agent | Biotech Hunter | Biotech Hunter